Cargando…

2747. Relative Vaccine Efficacy of High-Dose vs. Standard Dose Influenza Vaccines in Preventing Probable Influenza in a US Medicare Fee-for-Service Population

BACKGROUND: High dose (HD) influenza vaccine has been shown to be more efficacious than standard dose (SD) vaccine in multiple randomized trials. HD is currently the most commonly used vaccine in US seniors (≥65 years of age). In this study, we evaluated the real-world relative vaccine effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paudel, Misti, Mahmud, Salah, Buikema, Ami R, Korrer, Stephanie, Damon, Van Voorhis, Brekke, Lee, Chit, Ayman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809702/ http://dx.doi.org/10.1093/ofid/ofz360.2424

Ejemplares similares

A Map of Racial and Ethnic Disparities in Influenza Vaccine Uptake in the Medicare Fee-for-Service Program
por: Hall, Laura L., et al.
Publicado: (2020)

High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors
por: Becker, Debbie L., et al.
Publicado: (2016)

Economic Assessment of High-Dose Versus Adjuvanted Influenza Vaccine: An Evaluation of Hospitalization Costs Based on a Cohort Study
por: van Aalst, Robertus, et al.
Publicado: (2021)

Variation in influenza vaccine assessment, receipt, and refusal by the concentration of Medicare Advantage enrollees in U.S. nursing homes
por: Moyo, Patience, et al.
Publicado: (2022)

Efficacy and Effectiveness of High-Dose Influenza Vaccine for Older Adults: A Systematic Review and Meta-Analysis
por: Lee, Jason, et al.
Publicado: (2017)

High-dose influenza vaccination and mortality among predominantly male, white, senior veterans, United States, 2012/13 to 2014/15
por: Young-Xu, Yinong, et al.
Publicado: (2020)

Medicaid Fees and the Medicare Fee Schedule: An Update
por: Norton, Stephen A.
Publicado: (1995)

Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
por: Nham, Eliel, et al.
Publicado: (2023)

1168. Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
por: Nham, Eliel, et al.
Publicado: (2023)

1059 Expanded immunogenicity of high-dose inactivated influenza vaccine compared to standard-dose inactivated influenza vaccine in older adults
por: Diazgranados, Carlos, et al.
Publicado: (2014)

Optimal Dosing and Dynamic Distribution of Vaccines in an Influenza Pandemic
por: Wood, James, et al.
Publicado: (2009)

Gastrointestinal Events in High-Dose vs Standard-Dose Influenza Vaccine Recipients
por: Talbot, H Keipp, et al.
Publicado: (2018)

530 Disease Modulation in Older Adults Vaccinated with High-Dose Versus Standard-Dose Influenza Vaccine
por: Talbot, H. Keipp, et al.
Publicado: (2014)

2745. Efficacy and Effectiveness of High-Dose Influenza Vaccine for Older Adults by Circulating Strain and Antigenic Match: A Systematic Review and Meta-Analysis
por: Lee, Jason K H, et al.
Publicado: (2019)

Influenza vaccine in chronic obstructive pulmonary disease among elderly male veterans
por: Young-Xu, Yinong, et al.
Publicado: (2022)

Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom
por: Thommes, Edward W., et al.
Publicado: (2015)

Medicare Fee-for-Service Issues and Innovations
por: Cotterill, Philip
Publicado: (1997)

Determinants of Seasonal Influenza Vaccine Uptake Among the Elderly in the United States: A Systematic Review and Meta-Analysis
por: Okoli, George N., et al.
Publicado: (2019)

An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model
por: Chit, Ayman, et al.
Publicado: (2015)

The effect of delaying initiation with umeclidinium/vilanterol in patients with COPD: an observational administrative claims database analysis using marginal structural models
por: Buikema, Ami R., et al.
Publicado: (2018)

An Economic Evaluation of the Adjuvanted Quadrivalent Influenza Vaccine Compared with Standard-Dose Quadrivalent Influenza Vaccine in the Spanish Older Adult Population
por: Fochesato, Anna, et al.
Publicado: (2022)

Protective effect of single‐dose adjuvanted pandemic influenza vaccine in children
por: Van Buynder, P. G., et al.
Publicado: (2010)

Physician Fee Levels: Medicare Versus Canada
por: Welch, W. Pete, et al.
Publicado: (1993)

The Impact of Medicaid Adoption of the Medicare Fee Schedule
por: Holahan, John, et al.
Publicado: (1993)

Development and Validation of a Clinical Prediction Tool for Seasonal Influenza Vaccination in England
por: Loiacono, Matthew M., et al.
Publicado: (2020)

Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain
por: Ruiz-Aragón, Jesús, et al.
Publicado: (2022)

Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2019)

Seasonal influenza vaccination in older people: A systematic review and meta-analysis of the determining factors
por: Okoli, George N., et al.
Publicado: (2020)

2322. Effectiveness of Recombinant Influenza Vaccine vs. Standard Dose Inactivated Influenza Vaccines Against Hospitalized Influenza-Related Outcomes in Adults: A Cluster Randomized Trial
por: Hsiao, Amber, et al.
Publicado: (2022)

High-Dose Influenza Vaccine Is Associated With Reduced Mortality Among Older Adults With Breakthrough Influenza Even When There Is Poor Vaccine-Strain Match
por: Chaves, Sandra S, et al.
Publicado: (2023)

Optimizing the Dose of Pre-Pandemic Influenza Vaccines to Reduce the Infection Attack Rate
por: Riley, Steven, et al.
Publicado: (2007)

Characteristics of U.S. older adult medicare beneficiaries receiving the influenza vaccination at retail pharmacies
por: Liao, Chi-Yin, et al.
Publicado: (2023)

Effect of influenza vaccines against mismatched strains: a systematic review protocol
por: Tricco, Andrea C, et al.
Publicado: (2012)

29. Impact of Enhanced Influenza Vaccines on Direct Healthcare Costs for the U.S. Elderly: A Comprehensive Real-World Evaluation of Adjuvanted Trivalent Influenza Vaccine Compared to Trivalent High-Dose Influenza Vaccine for the 2018–19 Influenza Season
por: Postma, Maarten, et al.
Publicado: (2020)

Cost-Effectiveness of Vaccination of Older Adults with an MF59(®)-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden
por: Jacob, Jorge, et al.
Publicado: (2023)

2020-21 Influenza vaccination campaign strategy as a model for the third COVID-19 vaccine dose?
por: Lecce, Maurizio, et al.
Publicado: (2021)

Fee-for-Service Medicare in a Competitive Market Environment
por: Dowd, Bryan E., et al.
Publicado: (2005)

Productivity Adjustment in the Medicare Physician Fee Schedule Update
por: Newhouse, Joseph P., et al.
Publicado: (2007)

Payment Reduction and Medicare Private Fee-for-Service Plans
por: Frakt, Austin B., et al.
Publicado: (2009)

Allocating Practice Expense Under the Medicare Fee Schedule
por: Pope, Gregory C., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_h5la04ogj5n4piot3qr2r5h70l